A rare variant at the KYNU gene is associated with kynureninase activity and essential hypertension in the Han Chinese population.

Yi Zhang,Jie Shen,Xin He,Kuixing Zhang,Shengnan Wu,Bing Xiao,Xueya Zhou,Robert S Phillips,Pingjin Gao,Xavier Jeunemaitre,Dingliang Zhu
DOI: https://doi.org/10.1161/CIRCGENETICS.110.959064
2011-01-01
Abstract:Background-Genetic studies in mouse and human suggest that kynureninase activity may influence blood pressure and renal function. The gene coding kynureninase (KYNU) is also located on chromosome band 2q14-q23, where a linkage peak for essential hypertension was previously detected in the Chinese Han population. Methods and Results-After having found no association with common polymorphisms, this study aimed to assess the role of 1 rare variant of KYNU, Arg188Gln, and kynureninase activity in relation to hypertension. Thirty-three of 1124 Chinese patients with hypertension were heterozygous for Arg188Gln, whereas only 14 of 1084 normotensive controls were heterozygous for Arg188Gln (188G1n allele frequency, 0.015 versus 0.006; P=0.0075). A genotype-discordant sibling-pair study was performed in another 924 individuals from 213 families, indicating that 188G1n carriers had higher systolic blood pressure (168.29 +/- 24.67 versus 139.00 +/- 12.82 mm Hg, P < 0.001) and diastolic blood pressure (105.50 +/- 14.08 versus 90.75 +/- 11.07 mm Hg, P = 0.001) than did Arg188 homozygous siblings. The Arg188Gln variant was found to be rarer in 2 other ethnic groups (3 heterozygous among 880 hypertensive French whites and 0 of 90 black Africans with hypertension). The kynureninase activity in plasma was correlated with blood pressure in subjects from hypertensive families (P < 0.05). The Kinetic Michaelis constants of 188Gln carriers was lower than that of Arg188 homozygous subjects (0.05 +/- 0.02 versus 0.10 +/- 0.02 mmol/L, P = 0.005). Arg188Gln mutation in vitro also showed less catalytic efficiency than the wild-type KYNU enzyme (maximal reaction velocity/Kinetic Michaelis constant ratio, 0.050 +/- 0.012 versus 0.11 +/- 0.016 mL/min per mg; P = 0.029). Conclusions-The results show that the rare KYNU variant Arg188Gln affects kynureninase activity and are consistent with the hypothesis that this mutation can predispose to essential hypertension. (Circ Cardiovasc Genet. 2011;4:687-694.)
What problem does this paper attempt to address?